Glass House Brands GLAS
NYSE GLAS
$9.52 -0.18 (-1.86%)
As of: Aug 20, 2026 · 3:59 PM EDT

Glass House Brands (GLAS) Depreciation & Amortization (CF) (2020 - 2026)

Glass House Brands (GLAS) posted quarterly Depreciation & Amortization (CF) of $4.0 million for Q1 2026, up 4.82% year-over-year from $3.8 million in Q1 2025, and up 23.22% quarter-over-quarter from $3.3 million in Q4 2025.

Glass House Brands (GLAS) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $4.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) rose 4.82% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $15.2 million (changed 0.13% YoY), while the FY2025 annual figure was $15.0 million, changed 0.29% from the prior year.
  • Depreciation & Amortization (CF) improved to $4.0 million in Q1 2026 per GLAS's latest filing, from $3.3 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $4.0 million in Q1 2026 and bottomed at $2.6 million in Q1 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $3.6 million across 5 years, with a median of $3.7 million in 2024.
  • Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 339.13% — and 2025, when it fell 15.75%.
  • Glass House Brands' Depreciation & Amortization (CF) stood at $3.4 million in 2022, then advanced by 3.88% to $3.5 million in 2023, then advanced by 9.27% to $3.9 million in 2024, then fell by 15.75% to $3.3 million in 2025, then grew by 23.22% to $4.0 million in 2026.
  • Business Quant data shows GLAS's Depreciation & Amortization (CF) at $4.0 million in Q1 2026, $3.3 million in Q4 2025, and $4.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 241.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 119.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 1.02 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 24.20 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 672.30 Mn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 171.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Glass House Brands 837.25 Mn 818.69 Mn 15.77 Mn 3.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.02 Mn
Mar 31, 2026 4.02 Mn
Dec 31, 2025 3.26 Mn
Dec 31, 2025 3.26 Mn
Sep 30, 2025 3.99 Mn
Sep 30, 2025 3.99 Mn
Jun 30, 2025 3.91 Mn
Jun 30, 2025 3.91 Mn
Mar 31, 2025 3.84 Mn
Mar 31, 2025 3.84 Mn
Dec 31, 2024 3.87 Mn
Dec 31, 2024 3.87 Mn
Sep 30, 2024 3.73 Mn
Sep 30, 2024 3.73 Mn
Jun 30, 2024 3.72 Mn
Jun 30, 2024 3.72 Mn
Mar 31, 2024 3.72 Mn
Mar 31, 2024 3.72 Mn
Dec 31, 2023 3.55 Mn
Dec 31, 2023 3.55 Mn